Sabra Net Debt vs Other Assets Analysis
SBRA Stock | USD 18.52 0.11 0.60% |
Sabra Healthcare financial indicator trend analysis is much more than just breaking down Sabra Healthcare REIT prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sabra Healthcare REIT is a good investment. Please check the relationship between Sabra Healthcare Net Debt and its Other Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Net Debt vs Other Assets
Net Debt vs Other Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sabra Healthcare REIT Net Debt account and Other Assets. At this time, the significance of the direction appears to have weak relationship.
The correlation between Sabra Healthcare's Net Debt and Other Assets is 0.34. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Other Assets in the same time period over historical financial statements of Sabra Healthcare REIT, assuming nothing else is changed. The correlation between historical values of Sabra Healthcare's Net Debt and Other Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Sabra Healthcare REIT are associated (or correlated) with its Other Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Assets has no effect on the direction of Net Debt i.e., Sabra Healthcare's Net Debt and Other Assets go up and down completely randomly.
Correlation Coefficient | 0.34 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Other Assets
Most indicators from Sabra Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sabra Healthcare REIT current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At present, Sabra Healthcare's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 29.83, whereas Selling General Administrative is forecasted to decline to about 29.5 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 428.3M | 462.2M | 277.5M | 326.2M | Total Revenue | 569.5M | 624.8M | 655.8M | 404.9M |
Sabra Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Sabra Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sabra Healthcare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.1B | 6.0B | 6.0B | 5.7B | 5.4B | 4.2B | |
Short Long Term Debt Total | 2.4B | 3.7B | 4.2B | 2.7B | 2.4B | 2.2B | |
Other Current Liab | (1.2B) | (1.2B) | (1.8B) | (197.0M) | 1.5B | 1.6B | |
Total Current Liabilities | 108.8M | 146.3M | 143.0M | 142.3M | 1.8B | 1.9B | |
Total Stockholder Equity | 3.5B | 3.4B | 3.4B | 3.1B | 2.8B | 2.1B | |
Net Debt | 2.4B | 2.3B | 2.3B | 2.7B | 2.4B | 1.9B | |
Retained Earnings | (573.3M) | (716.2M) | (1.1B) | (1.5B) | (1.7B) | (1.6B) | |
Accounts Payable | 108.8M | 146.3M | 143.0M | 142.3M | 73.8M | 76.6M | |
Cash | 39.1M | 59.1M | 112.0M | 49.3M | 41.3M | 39.2M | |
Non Current Assets Total | 5.8B | 5.7B | 5.3B | 5.1B | 30.9M | 29.4M | |
Non Currrent Assets Other | 5.3B | 5.3B | 5.2B | 5.0B | (213.6M) | (202.9M) | |
Other Assets | 19M | 5.7B | 5.3B | 398.9M | 5.1B | 5.4B | |
Long Term Debt | 113.1M | 2.4B | 2.4B | 2.3B | 2.3B | 2.4B | |
Cash And Short Term Investments | 39.1M | 59.1M | 112.0M | 49.3M | 46.7M | 87.0M | |
Common Stock Total Equity | 2.1M | 2.1M | 2.3M | 2.3M | 2.7M | 2.8M | |
Common Stock Shares Outstanding | 188.1M | 207.3M | 219.1M | 230.9M | 232.8M | 131.1M | |
Liabilities And Stockholders Equity | 6.1B | 6.0B | 6.0B | 5.7B | 5.4B | 4.2B | |
Non Current Liabilities Total | 2.5B | 2.4B | 2.4B | 2.5B | 815.8M | 775.0M | |
Other Stockholder Equity | 4.6B | 4.9B | 5.6B | 4.5B | 4.5B | 2.9B | |
Total Liab | 2.6B | 2.6B | 2.6B | 2.7B | 2.6B | 2.0B | |
Total Current Assets | 307.0M | 329.0M | 653.1M | 613.2M | 212.7M | 387.9M | |
Accumulated Other Comprehensive Income | (12.4M) | (39.9M) | (10.0M) | 19.1M | 23.7M | 24.9M | |
Common Stock | 2.1M | 2.1M | 2.3M | 2.3M | 2.3M | 1.4M | |
Good Will | 167.1M | 131.1M | 101.5M | 82.8M | 95.2M | 53.1M | |
Retained Earnings Total Equity | (573.3M) | (716.2M) | (1.1B) | (1.5B) | (1.3B) | (1.2B) | |
Other Current Assets | (49.1M) | (65.5M) | (115.9M) | (411.4M) | 68.1M | 71.5M | |
Intangible Assets | 101.5M | 82.8M | 54.1M | 40.1M | 30.9M | 59.5M | |
Property Plant Equipment | 5.3B | 5.3B | 5.2B | 5.0B | 5.7B | 3.7B | |
Net Tangible Assets | 3.5B | 3.4B | 3.3B | 3.0B | 3.5B | 2.4B | |
Net Receivables | 257.8M | 263.5M | 537.2M | 147.9M | 103.3M | 98.1M | |
Long Term Debt Total | 113.1M | 2.4B | 2.4B | 2.3B | 2.7B | 2.8B | |
Capital Surpluse | 4.1B | 4.2B | 4.5B | 4.5B | 5.2B | 2.9B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.111 | Dividend Share 1.2 | Earnings Share 0.41 | Revenue Per Share 2.943 | Quarterly Revenue Growth 0.107 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.